ISNTREE HYALURONIC ACID DAILY SUNGEL
AVOBENZONE, HOMOSALATE, OCTISALATE · ISNTREE Inc. · TOPICAL
Open FDA's page for this record- Set ID
- 5a3a17ff-a7fd-f707-e063-6394a90a3182
- ID
- 5a3a1884-c8be-f786-e063-6394a90acdbb
- Effective time
- 20260829
- Version
- 1
- SPL product data elements
ISNTREE HYALURONIC ACID DAILY SUNGEL Avobenzone, Homosalate, Octisalate HOMOSALATE HOMOSALATE AVOBENZONE AVOBENZONE OCTISALATE OCTISALATE POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) XANTHAN GUM ADENOSINE DIETHYLHEXYL 2,6-NAPHTHALATE NIACINAMIDE CETYL ALCOHOL SILICON DIOXIDE PROPANEDIOL HYALURONIC ACID SODIUM PALMITOYL PROLINE GLYCERIN ETHYLHEXYLGLYCERIN SODIUM ACETYLATED HYALURONATE BUTYLENE GLYCOL DIMETHYLSILANOL HYALURONATE HYALURONATE SODIUM C20-22 ALCOHOLS TOCOPHEROL DIPROPYLENE GLYCOL PENTYLENE GLYCOL TROMETHAMINE CENTELLA ASIATICA TRITERPENOIDS HOUTTUYNIA CORDATA FLOWERING TOP PURSLANE ECTOINE WATER GLYCERYL MONOSTEARATE AMMONIUM ACRYLOYLDIMETHYLTAURATE, DIMETHYLACRYLAMIDE, LAURYL METHACRYLATE AND LAURETH-4 METHACRYLATE COPOLYMER, TRIMETHYLOLPROPANE TRIACRYLATE CROSSLINKED (45000 MPA.S) NYMPHAEA ALBA FLOWER BUTYLOCTYL SALICYLATE C20-22 ALKYL PHOSPHATE 1,2-HEXANEDIOL
- Active ingredient
- Active ingredients Avobenzone 2.7 % Homosalate 9 % Octisalate 4.5 %
- Purpose
- Purpose sunscreen
- Indications and usage
Uses • helps prevent sunburn • higher SPF gives more sunburn protection • if used as directed with other sun protection measures ( see Directions ) decreases the risk of skin cancer and early skin aging caused by the sun
- Warnings
- Warnings For external use only.
- Do not use
- Do not use • on damaged skin or broken skin.
- When using
- When using this product • keep out of eyes. Rinse with water to remove.
- Stop use
- Stop use and ask a doctor if •rash or irritation develops and lasts.
- Keep out of reach of children
- Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.
- Dosage and administration
Directions ■ apply liberally 15 minutes before sun exposure. Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 a.m. - 2 p.m. • wear long-sleeved shirts, pants, hats, and sunglasses ■ children under 6 months of age: Ask a doctor ■ reapply at least every 2 hours. ■ use a water-resistant sunscreen if swimming or sweating.
- Other safety information
Other information ■ protect the product from exessive heat and direct sun ■ Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risks of skin aging, skin cancer, and other harmful effects of the sun.
- Inactive ingredient
Inactive ingredients Water, Butyloctyl Salicylate, Butylene Glycol, Diethylhexyl 2,6-Naphthalate, Niacinamide, C20-22 Alkyl Phosphate, C20-22 Alcohols, 1,2-Hexanediol, Pentylene Glycol, Acrylates Copolymer, Polymethylsilsesquioxane, Cetyl Alcohol, Poly C10-30 Alkyl Acrylate, VP/Eicosene Copolymer, Glyceryl Stearate, Silica, Tromethamine, Propanediol, Polyacrylate Crosspolymer-6, Xanthan Gum, Ethylhexylglycerin, Adenosine, Portulaca Oleracea Extract, Centella Asiatica Extract, Houttuynia Cordata Extract, Hydrolyzed Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Dimethylsilanol Hyaluronate, Hyaluronic Acid, Sodium Hyaluronate, Potassium Hyaluronate, Sodium Hyaluronate Crosspolymer, Hydroxypropyltrimonium Hyaluronate, Sodium Hyaluronate Dimethylsilanol, Sodium Acetylated Hyaluronate, Tocopherol, Ectoin, Dipropylene Glycol, Sodium Palmitoyl Proline, Glycerin, Beta-Glucan, Nymphaea Alba Flower Extract
- Package label principal display panel
- ISNTREE HYALURONIC ACID DAILY SUN JEL 10ml ISNTREE HYALURONIC ACID DAILY SUN JEL 10ml
- Harmonized identifiers (openFDA)
- Application number
- M020
- Brand name
- ISNTREE HYALURONIC ACID DAILY SUNGEL
- Generic name
- AVOBENZONE, HOMOSALATE, OCTISALATE
- Manufacturer name
- ISNTREE Inc.
- Product NDC
- 81100-104
- Product type
- HUMAN OTC DRUG
- Route
- TOPICAL
- Substance name
- HOMOSALATE, AVOBENZONE, OCTISALATE
- SPL ID
- 5a3a1884-c8be-f786-e063-6394a90acdbb
- SPL set ID
- 5a3a17ff-a7fd-f707-e063-6394a90a3182
- Package NDC
- 81100-104-01, 81100-104-02
- Is original packager
- true
- UNII
- V06SV4M95S, G63QQF2NOX, 4X49Y0596W
